NFKB1 and COVID-19: Conclusively, a combined effect of young age population with lower comorbidities, epidemiological effects from highly incident helminth parasite infections and malaria endemic infection, together with a high coverage of anti-helminth and anti-malaria drugs with pronounced anti-inflammatory, i.e., NF-κB-inhibiting activity, may be responsible for the surprisingly low COVID-19-associated mortality rate in the sub-Saharan region of Africa.